The bleeding risk during warfarin therapy is associated with the number of variant alleles of CYP2C9 and VKORC1 genes

导出原文传递

翻译打印收藏纠错

作者： Tomek,A. ^[1] ; Ma?o?ka,V. ^[2] ; Kolá?ová,T. ^[3] ; Neumann,J. ^[4] ; ?rámek,M. ^[5] ; ?arbochová,I. ; Táborsky,L. ; Bojar,M. ; Goetz,P. ; Serebruany,V.L.

作者单位： Institute of Medical Genetics, Charles University, 2nd School of Medicine, Prague, Czech Republic ^[1] Neurology Department, Hospital Chomutov, Chomutov, Czech Republic ^[2] Neurology Department, Charles University, 2nd School of Medicine v, úvalu 84, CZ-150 04 Prague 5 ^[3] Molecular Genetics Laboratory, Hospital Na Homolce, Prague, Czech Republic ^[4] HeartDrug Research Laboratories, Johns Hopkins University, Baltimore, MD, United States ^[5]

关键词 Bleeding risk CYP2C9 gene Major bleeding event VKORC1 gene Warfarin

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交